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Nkx2.2 is a homeodomain-containing transcription factor essential for pancreatic islet cell specification. In this study we investigate the role of
Nkx2.2 within the small intestine. We have determined that Nkx2.2 is expressed at the onset of intestinal epithelial cell differentiation in specific
intestinal cell populations, including a subset of enteroendocrine cells. Similar to its role in the pancreatic islet, Nkx2.2 regulates cell fate choices
within the intestinal enteroendocrine population; in the Nkx2.2 null mice, several hormone-producing enteroendocrine cell populations are absent
or reduced and the ghrelin-producing cell population is upregulated. The remaining intestinal cell populations, including the paneth cells, goblet
cells, and enterocytes appear to be unaffected by the loss of Nkx2.2. Furthermore, similar to the pancreatic islet, Nkx2.2 appears to function
upstream of Pax6 in regulating intestinal cell fates; Pax6 mRNA and protein expression is decreased in the Nkx2.2 null mice. These studies
identify a novel role for Nkx2.2 in intestinal endocrine cell development and reveal the regulatory similarities between cell type specification in
the pancreatic islet and in the enteroendocrine population of the intestine.
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Intestinal development provides an excellent model system
for understanding the molecular mechanisms that regulate cell
fate decisions during embryogenesis. Numerous studies in a
variety of vertebrate species have defined many of the complex
developmental events that lead to the formation and differentia-
tion of the intestinal epithelium (reviewed in de Santa Barbara et
al., 2003; Hauck et al., 2005; Lee and Kaestner, 2004; Ng et al.,
2005; Roberts and Pearson, 2005; Wallace et al., 2005; Walters,
2005). Remarkably, this developmental process is conserved in
all vertebrates studied. These cumulative studies have demon-
strated the important early patterning events that occur along the
anterior–posterior axis to generate regional specification, as⁎ Corresponding author. Department of Genetics and Development, Columbia
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remaining dorsoventral, left–right, and radial axes to direct
general endodermal differentiation. Subsequent differentiation
of the endoderm occurs in response to epithelial-mesenchymal
interactions and gives rise to the functional epithelium, which
becomes organized into villi that project into the gut lumen and
the crypts that are embedded in the mesenchyme. The four
major differentiated cell types in the small intestine: goblet,
enteroendocrine, enterocyte, and paneth differentiate from a
common pluripotent stem cell, which is located in the crypt
(Cheng and Leblond, 1974). As they differentiate, the goblet,
enteroendocrine, and enterocyte cell populations migrate from
the crypt toward the villus tip, where they eventually die and
are extruded into the lumen. The paneth cells migrate downward
to reside at the base of the crypt. Within the epithelium, the
absorptive enterocytes are the predominant cell type. Of the
remaining cell types, the goblet cells secrete mucus, the
enteroendocrine cells secrete various hormones and growth
factors, and the paneth cells secrete antimicrobial compounds.
Table 1
Antibodies
Antigen Species Source Dilution
CCK Rabbit Diasorin 1:100
ChromograninA Rabbit Diasorin 1:100
Gastrin Rabbit Phoenix peptide 1:200
GIP Rabbit Phoenix peptide 1:200
Glucagon Guinea pig Linco 1:2000
Ghrelin Rabbit Phoenix peptide 1:500
Ghrelin Goat Santa Cruz 1:1000
Neurotensin Rabbit Phoenix peptide 1:200
Pax6 Rabbit Chemicon 1:250
PH3 Rabbit Upstate 1:250
PYY Guinea pig Research Diagnostic 1:500
Secretin Rabbit Phoenix peptide 1:200
Serotonin Rabbit Diasorin 1:1000
Substance P Rabbit Phoenix peptide 1:300
Synaptophysin Mouse Chemicon 1:10
59S. Desai et al. / Developmental Biology 313 (2008) 58–66Although the migration, morphology, and functions of each
cell population have been well characterized, the molecular
mechanisms that regulate the respective cell fate decisions are
unknown.
The enteroendocrine population only represents approxi-
mately 1% of the gut epithelial cells (Cheng and Leblond,
1974); however, this constitutes the largest population of
hormone producing cells in the body. Furthermore, the intestinal
enteroendocrine population is subdivided into at least 15
different cell types, which can be classified on the basis of
their morphology, expression of peptide hormone, and specific
marker expression. Recently several gene expression and
traditional transgenic knockout studies have identified some
of the signaling pathways and regulatory factors that are
involved in the development and differentiation of the
enteroendocrine population (reviewed in Lee and Kaestner,
2004; Schonhoff et al., 2004). Similar to their neuroendocrine
counterparts, Notch signaling plays a critical role in gut
endocrine cell fate decisions in the intestine and the pancreas
(Apelqvist et al., 1999; Fre et al., 2005; Jensen et al., 2000) and
represses the transcription factor Hes1, to allow the initiation of
cell differentiation. Subsequently, the bHLH molecules, Math1
and Neurogenin3 (Ngn3), are activated to initiate the endocrine
differentiation program (Jenny et al., 2002; Lee et al., 2002;
Yang et al., 2001). Further differentiation of the enteroendocrine
population into the 15 different subtypes is not well understood,
but mouse knockout studies have implicated several different
transcription factors in this process. Pdx1, a homeobox protein
that is essential for pancreatic development, is required for
development of several endocrine populations; serotonin,
secretin, and cholecystokinin (CCK) are reduced and gastrin
is absent in the duodenum of the Pdx1 null mice (Offield et al.,
1996). The bHLH protein NeuroD1/Beta2 is essential for the
formation of secretin and CCK cells (Naya et al., 1997) and the
paired homeodomain factors, Pax4 and Pax6, also affect the
differentiation of endocrine subtypes. Pax6 is required for
pancreatic glucagon production and the intestinal GLP-1 cell
formation. Pax4 is necessary for the production of most
endocrine cell types in the small intestine (Hill et al., 1999;
Larsson et al., 1998). Remarkably, each of these transcription
factors also differentially regulates pancreatic hormone expres-
sion and the development of pancreatic hormone-producing
islet cells (Miller et al., 1994; Naya et al., 1997; Offield et al.,
1996; Ohlsson et al., 1993; Sosa-Pineda et al., 1997; St-Onge et
al., 1997), implying that a conserved regulatory pathway exists
between the respective formation of intestinal and pancreatic
endocrine cell populations.
Nkx2.2 is a homeodomain transcription factor that is essential
for the differentiation of three of the pancreatic endocrine
populations (Sussel et al., 1998). In the islets of Nkx2.2 null
mice, the insulin, glucagon, and pancreatic polypeptide (PP)
populations are absent or reduced, and a population of cells
producing the peptide hormone ghrelin are upregulated (Prado et
al., 2004). Due to the profound effect of Nkx2.2 on the
specification of the islet endocrine populations and the strong
connection between pancreatic and intestinal regulatory path-
ways, we investigated the role of Nkx2.2 in mouse intestinaldevelopment. In this study, we demonstrate that Nkx2.2 is
expressed at the onset of intestinal epithelial differentiation in a
subset of enteroendocrine cells. This finding is consistent with a
recent study in zebrafish that demonstrates Nkx2.2 colocaliza-
tion with several enteroendocrine hormones in the intestine (Ng
et al., 2005). We also determine that, in the absence of Nkx2.2,
most intestinal hormones in the duodenum and jejunum are
absent or reduced and the ghrelin-producing cell population is
correspondingly increased, similar to what is observed in the
Nkx2.2 null islets. This finding further implicates Nkx2.2 as an
important regulator of many endocrine cell populations in the
intestine and pancreas, where it plays a critical role in
modulating cell fate specification to maintain a normal ratio of
endocrine cell populations. Interestingly, although the ultimate
endocrine cell identities are distinct within the pancreas and the
intestine, the role of Nkx2.2 in the two tissues is remarkably
conserved, suggesting that additional lineage-restricted tran-
scription factors will be required to contribute to the terminal
differentiation of each endocrine cell population and regulate
proper hormone production.
Materials and methods
Mice
Mice were maintained on a Swiss black (Taconic) background and were
housed in the University of Colorado Health Sciences Center animal resource
center. The mice were fed standard rodent chow and all animal procedures were
performed according to UCHSC Institutional Review Board approved protocols.
Immunohistochemistry and in situ hybridization
Tissue was fixed overnight in 4% paraformaldehyde, cryopreserved, and
cryosectioned into 10 μm sections. At e18.5, nN6 mutant embryos for each
antibody and RNA in situ probe assayed; at e15.5, nN5 for each RNA in situ probe
assayed. In each case, corresponding numbers of wild-type littermates were
simultaneously analyzed. Immunofluorescence was performed on cryopreserved
tissue with the primary antibodies listed in Table 1. Secondary antibodies include:
Alexa-fluor 488, 594, or 305 (Molecular Probes, Eugene, OR; 1:800).
RNA in situ hybridization was performed as previously described on e15.5
and e18.5 tissue (Prado et al., 2004) using antisense riboprobes transcribed from
linearized plasmids. Riboprobes for all genes except Nkx2.2 were generated
from full-length cDNAs, which were PCR-cloned from e17.5 intestinal RNA.
Table 2
Real-time PCR ABI assays on demand or custom probe/primer combinations
Mouse
gene
Probe 5′ or
Abi AOD #
Forward
primer 5′–3′
Reverse
primer 5′–3′
Gapdh Mm99999915_g1
Cdx1 Mm00438172_m1
Cdx2 Mm00432499_m1
Gata4 Mm00484689_m1
Gata6 Mm00802636_m1
Hes1 Mm00468601_m1
Isl1 Mm00627860_m1
Klf4 Mm00516104_m1
Math1 Mm004760355_s1
Mucin2 Mm004558299_m1
NeuroD1 Mm01280117_m1
Ngn3 cct gcg ctt cgc cca
caa ct
gac gcc aaa ctt
aca aag
gtc agt gcc cag
atg t
Nkx2.2 cca ttg act ctg ccc
cat cgc tct
cct ccc cga gtg
gca gat
gag ttc tat cct ctc
caa aag ttc aaa
Pax4 Mm01159043_g1
Pax6 Mm00443072_m1
Pdx1 Mm00435565_m1
Tcf4 Mm0043198_m1
TFF3 Mm00495590_m1
Cholecystokinin (CCK) Mm00446170_m1
ChromograninA (ChA) Mm0051431_m1
Gastrin Mm00772211_g1
Ghrelin (Ghrl) Mm00445450_m1
GIP Mm00433601_m1
Glucagon (Gcg) Mm00801712_m1
Neurotensin Mm00481140_m1
NPY Mm00445771_m1
PYY Mm00520715_m1
Secretin (Sct) Mm00441235_g1
Somatostatin (Sst) Mm00436671_m1
Substance P Mm00436880_m1
Synaptophysin Mm00436850_m1
Fig. 1. Nkx2.2 is expressed in the developing intestine. RNA in situ analyses of
Nkx2.2 expression at different embryonic stages. (a) e12.5; (b and c) e13.5; and
(c) e15.5. The boxed area is shown in higher magnification in panel d. (d) Higher
magnification of box shown in panel c. dp=dorsal pancreas, vp=ventral
pancreas, s=stomach, i= intestine.
60 S. Desai et al. / Developmental Biology 313 (2008) 58–66Full-length Nkx2.2 was cloned from a brain cDNA library (Porteus et al., 1992).
RNA in situs were performed on tissue from Nkx2.2 null embryos and a
corresponding number of wild-type littermates: villin (n=5), IFABP (n=4),
Cryptdin1 (n=9), Cryptdin6 (n=6), Cryptdin7 (n=10), Hes1 (n=3), Cdx1
(n=3), Cdx2 (n=3), Tcf4 (n=3), Math1 (n=4), Ngn3 (n=4), NeuroD1 (n=7),
Pax6 (n=5), and ghrelin (n=8). Nkx2.2 RNA in situs were performed on e12.5,
e13.5, e15.5, and e18.5 tissue. For combined Nkx2.2 RNA in situ and anti-
glucagon immunohistochemical analyses, the RNA in situs were performed to
completion followed by immunohistochemistry using rabbit anti-glucagon
antibody and biotinylated anti-rabbit secondary antibodies (Jackson Immunor-
esearch). The biotinylated secondary antibodies were visualized using the
Vectastain ABC kit (Vector labs). Images were obtained with a Leica DM5000
microscope and a Qimaging Evolution MP Color camera or a Nikon Eclipse 80i
microscope and a Qimaging Retiga EXi-Fast 1394 camera, and were processed
using ImagePro software from Media Cybernetics.
Cell counting
The total number of chromograninA, CCK, ghrelin, GIP, glucagon, PYY,
secretin, serotonin, PH3, and alcian blue positive cells was individually counted
and the total intestinal area was measured using standard morphometric analysis
with ImagePro software on every 10th section (10 μm each, 10 sections per
embryo) for wild-type (ChromograninA, CCK, GIP, glucagon, PH3 and alcian
blue: n=3; ghrelin, PYY, secretin, serotonin: n=7) and Nkx2.2−/− e18.5
embryos (ChromograninA, CCK, GIP, glucagon, PH3 and alcian blue: n=3;
ghrelin, PYY, secretin, serotonin: n=8). The number of immunoreactive cells per
cross-section was counted and normalized to the total intestinal area used in the
measurements. The results obtained from each embryo were averaged and
statistically analyzed.Quantitative real-time PCR
Total RNA was extracted from e18.5 wild-type and Nkx2.2−/− intestine
tissue (dissected between the pyloric sphincter on the anterior end to the caecum,
posteriorly) and prepared using the Qiagen RNeasy Micro kit. cDNAs were
prepared with random hexamer primers and Superscript III (Invitrogen). Real-
time PCR was performed on the ABI 7000 using Taqman probes (ABI Assays
on Demand) or individually designed Taqman probes and primers. Each gene
was normalized to Gapdh. See Table 2 for the list of primers and Supplemental
Table 1 for the numbers of samples tested for each probe. Samples were
quantified with ABI prism software.Results
Nkx2.2 is expressed in scattered cell populations throughout
the intestine during embryonic development
To determine when and where Nkx2.2 is expressed in the
developing mouse intestine, we performed RNA in situ analysis
to assess Nkx2.2 mRNA expression patterns throughout
embryogenesis. At e12.5, Nkx2.2 is expressed robustly in the
dorsal pancreas and in the emerging ventral pancreas, but cannot
be detected in the developing intestine (Fig. 1a). By e13.5, a small
number of Nkx2.2-producing cells can be detected in a few cells
of the proximal forestomach (Fig. 1b), but cannot be detected in
the developing proximal intestine (Fig. 1c and data not shown).
Between e14 and e15, cytodifferentiation of the intestinal
epithelium begins, and the four epithelial cell types (goblet,
enteroendocrine, enterocyte, and paneth) develop shortly after. At
this critical e15.5 time point, Nkx2.2 is first detected in scattered
Fig. 2. Nkx2.2 is expressed in the glucagon-producing enteroendocrine cells. RNA
in situ analysis of Nkx2.2 (purple) combined with immunoperoxidase staining of
glucagon-expressing cells (brown) at e18.5. (a) Co-staining of Nkx2.2 and
glucagon in enteroendocrine cells of the small intestine. The boxed areas are
shown in higher magnification in panels b–d. (b and c) Nkx2.2-positive, glucagon-
positive enteroendocrine cells (arrowheads). (d) Nkx2.2-positive, glucagon-
negative intestinal cell (arrows). (e) Co-staining of Nkx2.2 and glucagon in the
pancreatic islet. The boxed area is shown in higher magnification in panel f.
Fig. 3. In the Nkx2.2 null mice, many intestinal hormone-producing entero-
endocrine populations are reduced and ghrelin-producing cells are significantly
upregulated. (a–h) Immunofluorescence analysis of e18.5 wild-type (a, c, e, g,
and i) and Nkx2.2 null (b, d, f, h, j) mice. (a, b) Synaptophysin (green) costained
with DAPI (blue). Inset contains a higher magnification of a synaptophysin-
positive cell. (c, d) Serotonin (green) with a higher magnification inset of a
serotonin-positive cell. (e, f) CCK (green) with a higher magnification inset of a
CCK-positive cell. (g, h) GIP (green) with a higher magnification inset of a GIP-
positive cell. (i, j) Ghrelin expression (green) with higher magnification insets of
ghrelin-positive cells (green) costained with synaptophysin (red). (k, l) RNA in
situ analysis of ghrelin expression at e18.5.
61S. Desai et al. / Developmental Biology 313 (2008) 58–66cells throughout the duodenum and small intestine, and
expression is maintained through birth (Figs. 1d and e). At
perinatal stages, the position, spatial distribution, and shape of
Nkx2.2 positive cells in the intestinal epithelium are similar to
those of the enteroendocrine population. We confirmed that
Nkx2.2 was expressed in a subpopulation of enteroendocrine
cells by performing RNA in situ hybridization for Nkx2.2
combined with anti-glucagon immunohistochemical staining. As
shown in Fig. 2, Nkx2.2 is expressed in glucagon-positive cells of
the intestine. Because it can be difficult to visualize the co-stained
cells, representative coexpression of Nkx2.2 mRNA and
glucagon protein in the pancreas (where Nkx2.2 is known to be
co-expressed with glucagon (Sussel et al., 1998)) is also shown in
Figs. 2e and f. Consistent with Nkx2.2 being expressed in the
enteroendocrine cells, analysis of a transgenic line of zebrafish,
Tg(nkx2.2a:mEGFP) demonstrated co-expression of nkx2.2a
with the endocrine hormones, glucagon and somatostatin in the
intestinal epithelium (Ng et al., 2005).
Nkx2.2 is specifically required for appropriate cell type
specification of the enteroendocrine lineages
With the discovery that Nkx2.2 is expressed in specific cells of
the developing intestine, we wanted to determine whether
Nkx2.2 plays a role in intestinal epithelial development and
cell type differentiation, similar to its role in the pancreatic islet.
For this study, we analyzed mice that had been deleted for
Nkx2.2 (Sussel et al., 1998). Because the Nkx2.2 null mice die
shortly after birth with pancreatic islet and neural defects (Briscoeet al., 1999; Sussel et al., 1998), our analysis of the intestine was
restricted to the late embryonic stages, shortly after differentiation
of the intestinal epithelium is initiated. The Nkx2.2 null mice
appear to have no gross alterations in their intestinal morphology
when assessed by hemotoxylin and eosin (H&E) staining at any
stage during embryonic development (Figs. 5a and b). Since
Nkx2.2 has a known role in regulating endocrine cell fate
decisions in the pancreatic islet, the apparent expression of
Nkx2.2 in intestinal enteroendocrine cells led us to analyze the
enteroendocrine lineages of the gut epithelium in the Nkx2.2
knockout mice. Immunofluorescence analysis of several enter-
oendocrine hormones that are normally present in the proximal
small intestine demonstrated that many of these cell populations
were missing or reduced in the Nkx2.2 null mice (Fig. 3 and data
not shown). Quantification of serotonin, CCK, GIP, and gastrin
confirmed that there was a significant reduction in these
hormone-producing endocrine populations in the absence of
Nkx2.2 (Table 3). We confirmed that these and additional
Table 3
Enteroendocrine cells in wild-type and Nkx2.2−/− gastrointestinal tract
ChA CCK Ghrelin GIP Gcg PYY Sec Ser
Wild-type 57.1±5.6 29.5±2.1 12.4±4.1 47.9±4.3 15.2±3.4 24.4±2.3 27.6±1.4 65±5.1
Nkx2.2−/− 60.9±13.6 9.9±0.8∗∗ 44.6±13.3∗ 4.2±1.1∗ 4.7±1.7∗ 21.6±13.4 14.2±7.8 1.5±0.6∗
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performing real-time PCR analysis on mRNA collected from the
small intestine of wild-type and Nkx2.2 null animals. These
studies showed that the expression of CCK, gastrin, glucagon,
GIP, neurotensin, and somatostatin is significantly lower in the
Nkx2.2 null mice than in their wild-type littermates. Interestingly,
substance P and secretin expression is only moderately reduced.
The numbers of PYY-producing endocrine cells of the distal
small intestine were also unchanged in the Nkx2.2 null mice
(Table 3) and PYY and NPY were expressed at similar levels in
the wild-type and Nkx2.2 null mice, suggesting that these more
distal cell populations are unaffected by the loss of Nkx2.2.
Although there is a reduction in many of the hormone-
producing cells in the Nkx2.2 null mice, immunohistochemical
analysis of the pan-endocrine markers chromograninA and
synaptophysin suggested that the total numbers of enteroendo-
crine cells are unchanged (Fig. 3 and data not shown).
Quantification of the Chromogranin A immunoreactive cells
confirmed that there were similar numbers of enteroendocrine
cells in the wild-type and Nkx2.2 null small intestine (Table 3).
Chromogranin A and synaptophysin mRNA expression was
also unchanged in the Nkx2.2 null mice (Fig. 4). In contrast,
however, the number of cells expressing the ghrelin hormone is
significantly increased throughout the proximal small intestine
in the Nkx2.2 null embryos (Fig. 3 and Table 3) and ghrelin
mRNA expression is correspondingly elevated (Fig. 4). The
ghrelin-producing cells in the Nkx2.2 null mice appear to retain
the characteristics of endocrine cells as they continue to express
the endocrine marker synaptophysin (Fig. 3 inset and
Supplemental Fig. 1). This analysis suggests that, similar to
its role in the pancreatic islet, Nkx2.2 functions to regulate cellFig. 4. Quantification of hormone expression in e18.5 Nkx2.2 null small intestine. Rea
mutant small intestine. Note the change of scale for the comparative ghrelin expressio
type; ∗pb0.01; ∗∗pb0.001.fate specification of the enteroendocrine populations in the
intestine.
The loss of several hormone-producing populations and the
simultaneous increase in ghrelin-producing cells suggest that the
ghrelin cell population may be specified at the expense of the
other endocrine cell lineages. However, it remains possible that
the loss of Nkx2.2 activity increases the proliferation of the
existing ghrelin cell population, independently of losing the
other hormone-producing cells. To test this possibility, we
analyzed the expression of phospho-Histone H3 to assess the
mitotic status of the ghrelin-positive cells. Similar to our results
in the pancreatic islet, we could not detect any proliferating
ghrelin-positive cells in the intestine of wild-type or Nkx2.2 null
embryos (data not shown) and the total number of proliferating
cells in the intestine is not significantly altered when we
quantified the total number of phospo-histone H3 positive cells
(wild-type: 216.2±18.6 (n=3); Nkx2.2: 169±11.1 (n=3)).
Therefore, we hypothesize that in the absence of Nkx2.2 several
of the endocrine populations appear to be replaced by ghrelin-
producing endocrine cells.
Nkx2.2 does not affect the differentiation of the other intestinal
cell populations
The loss of several hormone-producing enteroendocrine
populations and corresponding upregulation of ghrelin cells in
the absence of Nkx2.2 activity confirms the importance of Nkx2.2
in intestinal enteroendocrine cell specification. However, because
we could not perform co-staining analysis of Nkx2.2 with the other
intestinal epithelial cell populations, we could not rule out that
Nkx2.2 was either directly or indirectly involved in thel-time PCR analysis of relative hormone expression in the Nkx2.2 wild-type and
n. See Supplemental Table 1 for numbers tested. Fold change normalized to wild-
Fig. 5. Nkx2.2 does not regulate the formation of non-enteroendocrine cell
populations in the small intestine. Analysis of intestinal cell populations in e18.5
embryos. (a, b) H&E staining of wild-type and mutant tissue. (c, d) RNA in situ
of villin-expressing intestinal epithelial cells. (e, f) Alcian blue staining of
intestinal goblet cells. (g, h) RNA in situ analysis of IFABP-expressing
enterocytes. (i, j) RNA in situ analysis of cryptdin1-producing paneth cells.
63S. Desai et al. / Developmental Biology 313 (2008) 58–66development and differentiation of other intestinal cell populations.
To determine whether Nkx2.2 affected the development of these
remaining intestinal cell types, we assessed the expression of
characteristic cell-type specific markers during intestinal develop-
ment (Fig. 4). Villin is one of the first genes to be expressed in the
intestine and is located globally throughout the intestinal epithelium
(Braunstein et al., 2002). We do not detect any change in villin
expression in the Nkx2.2 knockout mice suggesting that the early
intestinal patterning events are not perturbed (Figs. 5c and d). WeFig. 6. Intestinal transcription factor expression in Nkx2.2 wild-type and mutant
small intestine. RNA in situ analysis of transcription factor expression in wild-
type (a, c, e, g, i, and k) and Nkx2.2 null (b, d, f, h, j, and l) embryos. (a and b)
Tissue derived from e18.5 embryos; (c–l) tissue derived from e15.5 embryos. (m
and n) Immunofluorescent staining of Pax6 protein in wild-type and Nkx2.2 null
e18.5 embryos. Boxed area is shown in higher magnification in panels o and p.
Arrows point to Pax6-immunoreactive cells.
64 S. Desai et al. / Developmental Biology 313 (2008) 58–66were also unable to detect any defects in the development of the
mature enterocyte, goblet, or paneth cell populations by assessing
the expression of markers characteristic of each cell type (Fig. 5).
For this analysis, we assessed the expression of the enterocyte
marker IFABP, an intracellular protein abundantly expressed in the
differentiated enterocyte population, which represents the largest
cell population in the intestine (Figs. 5g and h); Alcian blue
labeling, which characteristically stains goblet cells (Figs. 5e and f),
and quantitative PCR analysis of two goblet cell specific genes,
TFF3 and mucin2 (n=5; Fig. 5k); and cryptdin1, 6, and 7 as
markers of paneth cell differentiation (Figs. 5i and j; data not
shown). According to this marker analysis, there were no
discernable differences in the non-endocrine cell populations
between the developing wild-type and Nkx2.2 null intestine.
Furthermore, quantification of the alcian blue stained cells revealed
that total goblet cell numbers were unchanged in the Nkx2.2 null
mice (wild-type: 182.9±5.6 (n=3); Nkx2.2−/−: 184.1±11.1
(n=3)) and expression of Klf4, a zinc finger transcription factor
that is essential for the terminal differentiation of goblet cells (Katz
et al., 2002), is also maintained. These studies indicate that Nkx2.2
is predominantly involved in the differentiation of the enteroendo-
crine intestinal cells and, similar to its role in the pancreatic islet,
plays an important role in cell specification decisions within this
population.
Positioning Nkx2.2 in the intestinal regulatory pathway
The increase in ghrelin cells at the expense of the several
intestinal endocrine populations has not been reported in other
mouse knockout models known to affect intestinal enteroendo-
crine cell differentiation. To better understand the molecular
basis of the defects observed in the Nkx2.2 knockout and to
position Nkx2.2 in the hierarchy of transcription factors
regulating intestinal cell fates, we assessed expression of
many of the regulatory factors known to be involved in
intestinal cell differentiation. Several different transcription
factors have been shown to regulate the cell type differentiation
process of all intestinal cell populations or the enteroendocrine
lineages, specifically. We used RNA in situ analysis and
quantitative real-time PCR to determine which, if any, of the
transcription factors had altered expression in the Nkx2.2
knockout mice (Figs. 6a–l and Supplemental Fig. 2). Consistent
with the Nkx2.2 mutant phenotype, which appears to be
restricted to the enteroendocrine lineages, expression of
transcription factors such as Cdx1 and Cdx2, which are
involved in early gut patterning, is not affected by the loss of
Nkx2.2 (Figs. 6a and b and Supplemental Fig. 2). In addition,
expression of the stem cell factor Tcf4, the progenitor cell
regulator Hes1, and the early cell lineage regulator Math1 is also
not affected in the mutant mice (Figs. 6c–f and Supplemental
Fig. 2). We also assessed the expression of the Gata4 and Gata6
transcription factors, which have recently been shown to be
differentially expressed in the enterocyte and enteroendocrine
populations of the gastrointestinal tract and the endocrine cells
of the pancreas (Bosse et al., 2006; Decker et al., 2006; Dusing
and Wiginton, 2005). Both by RNA in situ analysis and
quantitative PCR, we could not detect an alteration in Gata4 orGata6 expression in the Nkx2.2 null intestine (Supplemental
Fig. 2 and data not shown).
Many additional transcription factors are thought to be
responsible for the correct specification and/or development of
several enteroendocrine lineages. Ngn3 and NeuroD1/Beta2
(hereafter referred to as NeuroD1) are basic helix–loop–helix
transcription factors that are also involved in the endocrine cell
differentiation process. Ngn3 is required for the differentiation
of all endocrine cells in the gastrointestinal tract and pancreatic
islet; Ngn3 null mice fail to develop these populations. Ngn3
expression is not altered in the Nkx2.2 knockout mice (Figs.
6g–h and Supplemental Fig. 2), which is consistent with the
observation that there are normal numbers of enteroendocrine
cells in the Nkx2.2 null embryos. NeuroD1 has been shown to
function downstream of Ngn3 and appears to regulate the
formation of CCK and secretin cells (Huang et al., 2000; Jenny
et al., 2002; Naya et al., 1997). NeuroD1 mRNA expression is
modestly, but consistently downregulated in the intestine of
Nkx2.2 null mice (Supplemental Fig. 2); however, RNA in situ
analysis does not reflect a two-fold reduction in the area of
intestine staining for NeuroD1 (Figs. 6i–j). The discrepancy
between the PCR results and the RNA in situ analysis may be
due to the increased sensitivity of real-time PCR assay or may
reflect a decrease in the amount of NeuroD1 expressed in each
cell. The non-quantitative nature of RNA in situ assays makes
this issue difficult to resolve; however, a reduction in NeuroD1
expression the Nkx2.2 null mice is consistent with the
observed reduction in the numbers of CCK and secretin cell
populations.
Islet1 (Isl1) and Pdx1 play important regulatory roles in the
differentiation of islet and intestinal endocrine populations. It
has been suggested that the LIM homeodomain protein, Isl1, is
involved in the early differentiation of gastrin and somatostatin
cells; however, the early lethality associated with the Isl1
knockout mice precludes confirmation of an Isl1 intestinal
function (Ahlgren et al., 1997; Larsson, 2000). A deletion of the
homeodomain protein, Pdx1, however, results in a loss or
reduction of several endocrine cell populations in the duodenum
(Larsson et al., 1996). Although the Nkx2.2 knockout affects
many of the same endocrine cell populations, the expression
of both these genes is unaffected by the loss of Nkx2.2
(Supplemental Fig. 2).
Pax4 and Pax6 are also critical endocrine regulatory factors
that, similar to Nkx2.2, have been implicated in both pancreatic
and intestinal cell fate determination (Larsson et al., 1998). In
the intestine, Pax4 is essential for the formation of serotonin,
secretin, CCK, GIP, and PYY cells and Pax6 is required for GIP
cell differentiation. Interestingly, although it appears that Pax4
and Nkx2.2 regulate an overlapping set of intestinal cell types,
Pax4 expression is not affected in the Nkx2.2 knockout mice
(Supplemental Fig. 2). This would suggest that Pax4 functions
upstream of Nkx2.2 or in a parallel pathway for the formation of
several different enteroendocrine cell types. This result is
consistent with what we observe with corresponding Nkx2.2
and Pax4 functions in the pancreatic islet. Pax6, on the other
hand, is downregulated in the absence of Nkx2.2 (Figs. 6k–p),
suggesting that it functions downstream of Nkx2.2 to specify
65S. Desai et al. / Developmental Biology 313 (2008) 58–66GIP cells. Again, this parallels the corresponding functions of
Nkx2.2 and Pax6 in the islet.
Discussion
Nkx2.2 has previously been shown to be essential for the
appropriate differentiation of ventral spinal cord neurons,
oligodendrocytes, and pancreatic islet cells (Briscoe et al.,
2000; Prado et al., 2004; Qi et al., 2001; Sussel et al., 1998;
Zhou et al., 2001). In this study, we demonstrate that Nkx2.2
is also critical for the appropriate differentiation of enter-
oendocrine cells in the small intestine. We assessed the protein
and/or mRNA expression of many of the hormones produced
in the developing small intestine and found that several of
endocrine cell populations that populate the proximal small
intestine were reduced. Interestingly, these endocrine popula-
tions were not completely eliminated, suggesting that Nkx2.2-
independent differentiation programs exist, or compensatory
mechanisms are sometimes able to operate. Another Nkx
family member, Nkx6.1, is also expressed in the small
intestine, although analysis of Nkx6.1 in the intestine has not
yet been performed.
In addition to the reduction of several intestinal hormone-
producing populations in the Nkx2.2 knockout, we observed
a significant increase in the number of cells expressing
ghrelin, suggesting that some enteroendocrine populations
may be replaced by the ghrelin-producing cells. This is
similar to what is observed in the Nkx2.2 knockout
pancreatic islet, where the insulin-producing β cell popula-
tion and most glucagon-producing α cells are also replaced
by the ghrelin cells. This cell type conversion implies that
Nkx2.2 plays an early role in specifying endocrine cell
identities and, in its absence, the differentiation pathway
either defaults or is diverted to the ghrelin cell fate.
Alternatively, it is possible that cell fate changes have not
occurred in the intestine of Nkx2.2 null mice, but instead
Nkx2.2 differentially regulates hormone expression at the
transcriptional level; the hormones that are lost would be
activated by Nkx2.2 and ghrelin would be repressed by
Nkx2.2. While there were additional cell-specific markers to
demonstrate that the ghrelin-producing cells in the Nkx2.2
null islet were not molecularly identical to α or β cells,
similar molecular tools are not yet available for the intestinal
endocrine cell populations. We have, however, determined
that Nkx2.2 does not repress transcription of the mouse or
human ghrelin promoter in αTC and HCT8 cell lines, which
both express ghrelin endogenously (Christina Chao and Lori
Sussel, unpublished data). Further analysis of the individual
enteroendocrine populations affected in the Nkx2.2 null mice
will be necessary to determine the mechanism by which
Nkx2.2 functions to regulate endocrine cell fates and
hormone expression in the intestine.
Similar to many of the other intestinal transcription factors,
which predominantly regulate the development of small
subsets of enteroendocrine cell populations, deletion of
Nkx2.2 does not affect all hormone-producing endocrine
populations in the small intestine. Furthermore, the affectedendocrine cell populations are variably reduced. This is
similar to what is observed in the pancreatic islet, where
Nkx2.2 is required for the formation of all insulin-producing
β cells, and only subsets of the glucagon-producing α cells
and PP cells. This would suggest that unlike Ngn3, Nkx2.2 is
not a global regulator of the endocrine cell populations, but
functions at a later stage to specify the differentiation of
specific endocrine cell fates. Interestingly, Nkx2.2 is not
required for the formation of the somatostatin-expressing δ
cell population in the islet, whereas it is required for the
expression of somatostatin in the intestine. This further
underscores that while there are obvious similarities between
the endocrine cell populations in the intestine and pancreas,
fundamental regulatory differences exist in each cell type as
well.
It is interesting that the ghrelin cell population is
upregulated in both the islet and small intestine when
Nkx2.2 is deleted. This suggests that mechanisms by which
Nkx2.2 controls some of the early general fate decisions in
the pancreas and intestine are conserved. Consistent with this,
several other transcription factors commonly regulate cell fate
decisions in the islet and intestine (reviewed in Lee and
Kaestner, 2004; Schonhoff et al., 2004). Furthermore, our
study has demonstrated that portions of the transcriptional
regulatory pathway may also be conserved between the two
tissues: in Nkx2.2-deficient pancreas and intestine, Pdx1,
Ngn3, and Pax4 expression is unaffected, while Pax6 and
NeuroD1 expression is reduced. What is remarkable about
this conservation is that the ultimate cell fates and hormone
products of the islet and gut endocrine cells are different. We
propose that although these common regulatory factors may
contribute to the final cell fate decisions, unique combinations
of additional tissue and cell type specific proteins will be
required to initiate the different terminal differentiation
pathways and differential hormone expression. Currently
there is limited information regarding the lineage relationships
between the many enteroendocrine populations; these types of
analyses will be essential to unraveling the regulatory
pathways and cell fate decision processes that distinguish
islet and intestinal endocrine populations, as well as the
events that regulate differentiation of each endocrine cell
subpopulation. However, the similarities between early islet
and intestinal endocrine differentiation regulatory pathways
also suggest that the well-characterized intestinal stem cell
population could be harnessed to produce alternative sources
of islet cells for therapeutic purposes.
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